Biogen CEO Michel Vounatsos' 2018 pay rises 18% to $16M
Biogen reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
Biogen reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, five Biogen executives received on average a compensation package of $7.9M, a 53% increase compared to previous year.
Average pay of disclosed executives at Biogen
Michel Vounatsos, Chief Executive Officer, received $16M in total, which increased by 18% compared to 2017. 68% of Vounatsos' compensation, or $11M, was in stock awards. Vounatsos also received $81K of change in pension value and nonqualified deferred compensation earnings, $3.3M in non-equity incentive plan, $1.3M in salary, as well as $408K in other compensation.
For fiscal year 2018, the median employee pay was $170,521 at Biogen. Therefore, the ratio of Michel Vounatsos' pay to the median employee pay was 95 to one.
Michael D. Ehlers, Executive Vice President, Research & Development, received a compensation package of $7M, which increased by 39% compared to previous year. 72% of the compensation package, or $5.1M, was in stock awards.
Susan H. Alexander, Chief Legal Officer, earned $6.4M in 2018, a 26% increase compared to previous year.
Paul F. McKenzie, Executive Vice President, Pharmaceutical Operations & Technology, received $5.7M in 2018, which increases by 13% compared to 2017.
Jeffrey D. Capello, Chief Financial Officer, earned $4.5M in 2018, a 715% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 30, 2019.